Literature DB >> 3711278

Persistence of chlamydial antibodies after pelvic inflammatory disease.

M Puolakkainen, E Vesterinen, E Purola, P Saikku, J Paavonen.   

Abstract

The persistence of chlamydial immunoglobulin G (IgG) antibodies and long-term sequelae of pelvic inflammatory disease (PID) were studied in 70 women who had been treated for PID 3 to 6 years previously. Fifty-one women had had PID associated with Chlamydia trachomatis infection (Chlamydia group), and 19 women had had PID not associated with C. trachomatis (non-Chlamydia group). Chlamydial IgG antibodies, as determined by the indirect immunofluorescence test with inclusions of C. trachomatis L2 as antigens, persisted at stable levels in 43% of the women for up to 6 years; 43% of the women showed a decrease in IgG titer, and 13% showed an increase. IgA antibody levels in serum correlated with IgG antibody levels in serum and with the presence of cervical IgA antibodies. Both serum antibodies and cervical IgA antibodies were more often found in the Chlamydia group. Forty-two percent of the women were infertile. Every fifth subsequent pregnancy was ectopic. The presence of cervical IgA antibodies might protect the women from tubal damage.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711278      PMCID: PMC268751          DOI: 10.1128/jcm.23.5.924-928.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  24 in total

1.  Effect of acute pelvic inflammatory disease on fertility.

Authors:  L Weström
Journal:  Am J Obstet Gynecol       Date:  1975-03-01       Impact factor: 8.661

2.  Epidemiology of ornithosis and psittacosis.

Authors:  F DEKKING
Journal:  Arch Gesamte Virusforsch       Date:  1963

Review 3.  Chlamydial infections (third of three parts).

Authors:  J Schachter
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

4.  Studies on gonococcus infection. XVII. IgA1-cleaving protease in vaginal washings from women with gonorrhea.

Authors:  M Blake; K K Holmes; J Swanson
Journal:  J Infect Dis       Date:  1979-01       Impact factor: 5.226

5.  Chlamydia trachomatis in acute salpingitis.

Authors:  J Paavonen; P Saikku; E Vesterinen; K Aho
Journal:  Br J Vener Dis       Date:  1979-06

6.  Genital chlamydial infections in patients attending a gynaecological outpatient clinic.

Authors:  J Paavonen; P Saikku; E Vesterinen; B Meyer; E Vartiainen; E Saksela
Journal:  Br J Vener Dis       Date:  1978-08

7.  Single-antigen immunofluorescence test for chlamydial antibodies.

Authors:  P Saikku; J Paavonen
Journal:  J Clin Microbiol       Date:  1978-08       Impact factor: 5.948

8.  Chlamydia trachomatis in women: antibody in cervical secretions as a possible indicator of genital infection.

Authors:  D E McComb; R L Nichols; D Z Semine; J R Evrard; S Alpert; V A Crockett; B Rosner; S H Zinner; W M McCormack
Journal:  J Infect Dis       Date:  1979-06       Impact factor: 5.226

9.  Rapid diagnosis of chlamydial infection of the cervix.

Authors:  J D Treharne; S Darougar; P D Simmons; R N Thin
Journal:  Br J Vener Dis       Date:  1978-12

10.  Antibodies to Chlamydia trachomatis in acute salpingitis.

Authors:  J D Treharne; K T Ripa; P A Mårdh; L Svensson; L Weström; S Darougar
Journal:  Br J Vener Dis       Date:  1979-02
View more
  28 in total

1.  Laboratory survey of Chlamydia trachomatis ocular infections.

Authors:  E Gulletta; M Del Pezzo; A Del Prete; I Covelli
Journal:  Eur J Epidemiol       Date:  1990-09       Impact factor: 8.082

2.  Induction of antibody response to Chlamydia trachomatis in the genital tract by oral immunization.

Authors:  Z D Cui; D Tristram; L J LaScolea; T Kwiatkowski; S Kopti; P L Ogra
Journal:  Infect Immun       Date:  1991-04       Impact factor: 3.441

Review 3.  Laboratory techniques for the diagnosis of chlamydial infections.

Authors:  D Taylor-Robinson; B J Thomas
Journal:  Genitourin Med       Date:  1991-06

4.  Antibody to Chlamydia trachomatis proteins, TroA and HtrA, as a biomarker for Chlamydia trachomatis infection.

Authors:  K Hokynar; S Korhonen; P Norja; J Paavonen; M Puolakkainen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-09-14       Impact factor: 3.267

Review 5.  [Urogenital chlamydial infections in women and men].

Authors:  A Clad; W Krause
Journal:  Hautarzt       Date:  2007-01       Impact factor: 0.751

6.  Validity of self-reported history of Chlamydia trachomatis infection.

Authors:  Ann C Frisse; Jeanne M Marrazzo; Nhial T Tutlam; Courtney A Schreiber; Stephanie B Teal; David K Turok; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2016-12-14       Impact factor: 8.661

7.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

9.  Prevalence of IgA and IgG antichlamydial antibodies in women in the third trimester of pregnancy.

Authors:  N G Osborne; Y Hecht; J Gorsline; B A Forbes; F Morgenstern; J Winkelman
Journal:  J Natl Med Assoc       Date:  1988-11       Impact factor: 1.798

10.  Detection of serum antibodies to Chlamydia trachomatis in patients with chlamydial and nonchlamydial pelvic inflammatory disease by the IPAzyme Chlamydia and enzyme immunoassay.

Authors:  A Mattila; A Miettinen; P K Heinonen; K Teisala; R Punnonen; J Paavonen
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.